Latest Payments News

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.

Kairos Minerals has raised approximately A$27 million through a premium share placement to fund drilling and development at its Mt York and Roe Hills gold projects in Western Australia, attracting robust demand from institutional investors.

Regal Partners Limited reported a robust 13.1% increase in funds under management to $20 billion, driven by strong client inflows and positive investment returns. Performance fees for the second half of 2025 are tracking well above broker expectations, signaling strong momentum.

Saunders International has completed its acquisition of Aqua Metro, a key player in Victoria's water infrastructure sector, marking a strategic expansion into multidisciplinary water projects.

Audeara Limited has landed its maiden purchase order for hearing aid technology in China, marking a pivotal step in its global expansion with production and launch planned for the final quarter of 2025.

Great Dirt Resources reports promising lithium soil anomalies in Western Australia's Pilbara region and progresses manganese exploration in New South Wales, supported by a solid cash position of $2.4 million.

Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.

Ryder Capital Limited has announced a 20% increase in its annual dividend, moving to quarterly payments starting January 2026, enhancing income certainty for shareholders.

Ryder Capital Limited celebrated its 10th year on the ASX with robust FY25 results, including a 27.5% pre-tax NTA growth and a new quarterly dividend policy increasing payouts by 20%. The company also renewed its investment management agreement for five years.

MFF Capital Investments Limited has confirmed a fully franked dividend of AUD 0.09 per share for the six months ending June 2025, alongside updated Dividend Reinvestment and Bonus Security Plan prices.

BlackRock Investment Management has released the estimated distribution components for its iShares S&P/ASX Dividend Opportunities ESG Screened ETF for the period ending 9 October 2025, highlighting key income sources and tax considerations.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.